AAAAAA

   
Results: 1-15 |
Results: 15
Melting temperature analysis as quantitative method for detection of pointmutations
Authors: Porcelli, B Frosi, B Terzuoli, L Arezzini, L Pagani, R Civitelli, S Tanzini, G Orlando, C Pazzagli, M Marziliano, N Da Prato, L
Citation: B. Porcelli et al., Melting temperature analysis as quantitative method for detection of pointmutations, CLIN CH L M, 39(6), 2001, pp. 501-504
Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the TaqMan (TM) detection system
Authors: Gelmini, S Tricarico, C Vona, G Livi, L Della Melina, A Semi, S Cellai, E Magrini, S Villari, D Carini, M Serio, M Forti, G Pazzagli, M Orlando, C
Citation: S. Gelmini et al., Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the TaqMan (TM) detection system, CLIN CH L M, 39(5), 2001, pp. 385-391
Telomerase in endocrine and endocrine-dependent tumors
Authors: Orlando, C Gelmini, S
Citation: C. Orlando et S. Gelmini, Telomerase in endocrine and endocrine-dependent tumors, J STEROID B, 78(3), 2001, pp. 201-214
Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan (TM) technology
Authors: Pinzani, P Orlando, C Raggi, CC Distante, V Valanzano, R Tricarico, C Maggi, M Serio, M Pazzagli, A
Citation: P. Pinzani et al., Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan (TM) technology, REGUL PEPT, 99(2-3), 2001, pp. 79-86
Somatostatin receptor type 2 gene expression in neuroblastoma, measured bycompetitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium-111-pentetreotide
Authors: Orlando, C Raggi, CC Bagnoni, L Sestini, R Briganti, V La Cava, G Bernini, G Tonini, G Pazzagli, M Serio, M Maggi, M
Citation: C. Orlando et al., Somatostatin receptor type 2 gene expression in neuroblastoma, measured bycompetitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium-111-pentetreotide, MED PED ONC, 36(1), 2001, pp. 224-226
Telomerase in urological malignancy
Authors: Orlando, C Gelmini, S Selli, C Pazzagli, M
Citation: C. Orlando et al., Telomerase in urological malignancy, J UROL, 166(2), 2001, pp. 666-673
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay
Authors: Gelmini, S Crisci, A Salvadori, B Pazzagli, M Selli, C Orlando, C
Citation: S. Gelmini et al., Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay, CLIN CANC R, 6(7), 2000, pp. 2771-2776
Asymmetric carbolithiation of 2-phenylselenofumarate derivatives: a short synthesis of (-)-roccellaric acid
Authors: Bella, M Margarita, R Orlando, C Orsini, M Parlanti, L Piancatelli, G
Citation: M. Bella et al., Asymmetric carbolithiation of 2-phenylselenofumarate derivatives: a short synthesis of (-)-roccellaric acid, TETRAHEDR L, 41(4), 2000, pp. 561-565
Osteopathic treatment of low back pain.
Authors: Orlando, C Field, L
Citation: C. Orlando et L. Field, Osteopathic treatment of low back pain., N ENG J MED, 342(11), 2000, pp. 819-819
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome
Authors: Raggi, CC Maggi, M Renzi, D Calabro, A Bagnoni, ML Scaruffi, P Tonini, GP Pazzagli, M De Bernardi, B Bernini, G Serio, M Orlando, C
Citation: Cc. Raggi et al., Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome, J CLIN END, 85(10), 2000, pp. 3866-3873
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas
Authors: Mannelli, M Gelmini, S Arnaldi, G Becherini, L Bemporad, D Crescioli, C Pazzagli, M Mantero, F Serio, M Orlando, C
Citation: M. Mannelli et al., Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas, J CLIN END, 85(1), 2000, pp. 468-470
Analysis of 12q13-15 genes in parosteal osteosarcoma
Authors: Gamberi, G Ragazzini, P Benassi, MS Ferrari, C Sollazzo, MR Molendini, L Merli, M Magagnoli, G Ruggieri, P Balladelli, A Orlando, C Bacchini, P Pazzagli, M Picci, P
Citation: G. Gamberi et al., Analysis of 12q13-15 genes in parosteal osteosarcoma, CLIN ORTHOP, (377), 2000, pp. 195-204
The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples
Authors: Vona, G Caldini, A Sestini, R Rapi, S Bianchi, S Fanelli, A Pazzagli, M Orlando, C
Citation: G. Vona et al., The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples, CLIN CH L M, 37(6), 1999, pp. 649-654
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma
Authors: Ragazzini, P Gamberi, G Benassi, MS Orlando, C Sestini, R Ferrari, C Molendini, L Sollazzo, MR Merli, M Magagnoli, G Bertoni, F Bohling, T Pazzagli, M Picci, P
Citation: P. Ragazzini et al., Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma, CANCER DET, 23(2), 1999, pp. 129-136
Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system
Authors: Raggi, CC Bagnoni, ML Tonini, GP Maggi, M Vona, G Pinzani, P Mazzocco, K De Bernardi, B Pazzagli, M Orlando, C
Citation: Cc. Raggi et al., Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system, CLIN CHEM, 45(11), 1999, pp. 1918-1924
Risultati: 1-15 |